Skip to main navigation
  • Careers
  • Contact Us
Exelixis
  • Our Story
    • Mission
    • Leadership
    • Board of Directors
    • Collaborations
  • Medicines
    • Our Medicines
    • Access
  • Research & Development
    • Research and Development
    • Pipeline
      • Pipeline Overview
      • Early-Stage Compounds
      • Cabozantinib Pipeline
      • Other Partnered Programs
    • Clinical Trials
  • Impact
    • Why Cancer?
    • Patient Stories
    • Grants & Giving
    • Corporate Values & Sustainability
    • Statement on COVID-19
  • Investors & Media
    • Investors Overview
    • News and Events
      • Press Releases
      • Event Calendar
      • Media Resources
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
      • Earnings Estimates
    • Financial Information
      • Annual Reports
      • SEC Filings
      • Interactive Analyst Center
    • Investor Resources
      • Investor FAQs
      • Corporate Values & Sustainability
      • Information Request
    • Corporate Governance
      • Corporate Governance Documents and Information
      • Leadership
      • Board of Directors
      • Committee Composition and Charters
    • Contact IR
Select Page

Investors & Media

Press Releases

02/02/23
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in February
Printer Friendly Version 
01/24/23
Exelixis to Release Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023
Printer Friendly Version 
01/19/23
Exelixis Announces Update on Patent Litigation with MSN Laboratories
Printer Friendly Version 
01/08/23
Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023
Printer Friendly Version 
01/03/23
Exelixis to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023 —  Presentation to be webcast on www.exelixis.com  —
Printer Friendly Version 

Investor Relations

  • Investors Overview
  • News & Events
    • Press Releases
    • Event Calendar
    • Media Resources
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
    • Earnings Estimates
  • Financial Information
    • Annual Reports
    • SEC Filings
    • Interactive Analyst Center
  • Investor Resources
    • Investor FAQs
    • Corporate Values & Sustainability
    • Information Request
  • Corporate Governance
    • Corporate Governance Documents and Information
    • Leadership
    • Board of Directors
    • Committee Composition and Charters
  • Contact IR

Receive Email Alerts

Sign up to receive email alerts whenever Exelixis, Inc. posts new information to the site. Just enter your email address and click Sign Up.
Required fields denoted by an asterisk ().
Alert type

Shareholder Tools

  • Information Request
  • Print Page
  • Email Alerts
  • RSS
Tweets by ExelixisInc

Our Story

  • Mission
  • Leadership
  • Board of Directors
  • Collaborations

Medicines

  • Our Medicines
  • Access

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Trials

Impact

  • Why Cancer?
  • Patient Stories
  • Grants & Giving
  • Corporate Values & Sustainability
  • Statement on COVID-19

Investors & Media

    Investors & Media

    • Investors Overview
    • News & Events
    • Stock Information
    • Financial Information
    • Investor Resources
    • Corporate Governance
    • Contact IR
  • Facebook
  • Twitter
© Exelixis, Inc. 2023
  • Ethics & Compliance
  •  Privacy
  •  Terms of Use

This website uses cookies to improve and personalize content and for tracking and analytics. You can learn more from our Privacy Statement.

OK